SET, ADMINISTRATION, FOR PERITONEAL DIALYSIS, DISPOSABLE
Report
- Report Number
- 1416980-2013-18776
- Event Type
- Injury
- Date Received
- July 17, 2013
- Date of Event
- June 23, 2013
- Report Date
- June 23, 2013
- Manufacturer
- BAXTER HEALTHCARE
- Product Code
- KDJ
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- RP
- Reporter Occupation
- PHYSICIAN
Narratives
COMPLAINT NO: (B)(4). BAXTER HAS CONDUCTED A TREND REVIEW AND FOUND THAT SIMILAR REPORTS HAVE BEEN RECEIVED FOR THE REPORTED PROBLEM. BAXTER WILL CONTINUE TO MONITOR SIMILAR REPORTS TO DETERMINE IF FURTHER ACTIONS ARE REQUIRED. THE DEVICE WAS NOT RETURNED; THEREFORE, A DEVICE ANALYSIS COULD NOT BE PERFORMED. THE CAUSE OF THIS PERITONITIS WAS USE ERROR DESCRIBED AS A BREAK IN ASEPTIC TECHNIQUE. PER BAXTER LABELING, USERS ARE INSTRUCTED TO USE ASEPTIC TECHNIQUE WHEN PERFORMING PERITONEAL DIALYSIS THERAPY. A FORMAL REVIEW OF THE LABEL FOR THE PRODUCT FAMILY WILL BE CONDUCTED. IF THERE IS ANY FURTHER RELEVANT INFORMATION, A SUPPLEMENTAL MEDWATCH WILL BE SUBMITTED.
IT WAS REPORTED THAT THE PATIENT EXPERIENCED A BREAK IN ASEPTIC TECHNIQUE WHICH CAUSED PERITONITIS MANIFESTED BY CLOUDY PERITONEAL EFFLUENT. THIS OCCURRED DURING CONTINUOUS AMBULATORY PERITONEAL DIALYSIS (CAPD) THERAPY WHILE USING UNKNOWN BAXTER DISPOSABLES. PERITONITIS WAS DIAGNOSED WHILE THE PATIENT WAS HOSPITALIZED FOR AN UNREPORTED REASON. IT WAS NOT REPORTED IF THE PERITONITIS PROLONGED THE HOSPITALIZATION STAY. AT THE TIME OF THIS REPORT, ANTIBIOTICS HAD NOT YET BEEN INITIATED AS SOME OF THE LAB RESULTS WERE STILL PENDING. OUTCOME OF PERITONITIS WAS NOT REPORTED. ADDITIONAL INFORMATION WAS REQUESTED, BUT IS NOT AVAILABLE AT THIS TIME.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 332493 | SET, ADMINISTRATION, FOR PERITONEAL DIALYSIS, DISPOSABLE | KDJ | BAXTER HEALTHCARE |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 45 YR | Other | DIANEAL PD2 1.5% AND 4.25% |